The programme brings together world leaders from international pharmaceutical organisations and leading biotechnology companies as well as globally active regulatory agencies to discuss the latest advances in gene therapy.
Engage in scientific discussions on the latest tools and technologies for gene therapy drug discovery and analytics
Gain insights into the innovative technologies in gene editing, including CRISPR, ZFNs and TALENS and the translation of these technologies to clinical research
Explore methods to accelerate drug development through translational gene therapy, with presentations focussing on modelling, prediction of response, biomarkers and surrogate endpoints
05 May – Day One
06 May – Day Two
The 2021 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Bristol-Myers Squibb
Selecta Biosciences
Asklepios BioPharmaceutical Inc
Sangamo Therapeutics
Asklepios BioPharmaceutical Inc
Sarepta Therapeutics
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of features and make the most of participation in a range of virtual experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.